-Reuters
HC Wainwright & Co. Downgrades Imago BioSciences to Neutral, Raises Price Target to $36
HC Wainwright & Co. analyst Mitchell Kapoor downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Neutral and raises the price target from $35 to $36.